Vitamin E and Folic Acid: study protocols
22 study groups took Vitamin E together with Folic Acid. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: Vitamin E
15 study groups in 12 studies say how much Vitamin E participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 25 mg to 50 mg, 40% of 15 study groups.
| Daily dose | Study groups |
|---|---|
| 5 mg or less | 1 |
| 5 mg to 10 mg | 2 |
| 10 mg to 25 mg | 2 |
| 25 mg to 50 mg | 6 |
| 50 mg to 100 mg | 1 |
| 100 mg to 250 mg | 1 |
| 250 mg to 500 mg | 1 |
| over 500 mg | 1 |
Dose per serving from research: Folic Acid
22 study groups in 16 studies say how much Folic Acid participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 250 mcg to 500 mcg, 45% of 22 study groups.
| Daily dose | Study groups |
|---|---|
| 100 mcg to 250 mcg | 3 |
| 250 mcg to 500 mcg | 10 |
| 500 mcg to 1 mg | 4 |
| 1 mg to 2.5 mg | 1 |
| 2.5 mg to 5 mg | 3 |
| over 5 mg | 1 |
Commonly used together
22 of 22 study groups took Vitamin E and Folic Acid with something else. Shown: what 3 or more different studies gave. The 10 most common of 11.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Vitamin B12 | 14 |
| Vitamin C | 14 |
| Vitamin B6 | 9 |
| Selenium | 6 |
| Zinc | 6 |
| Vitamin D | 5 |
| Copper | 4 |
| Iron | 4 |
| Vitamin A | 4 |
| Iodine | 3 |
22 study groups
| Study | ||||
|---|---|---|---|---|
| Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly 2004 · special nutritional formula · Healthy adults aged 70 years or older with Mini Mental score ≥22 | 120 IU | 400 mcg | 1 year | 30 |
| Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal 2003 · Multiple micronutrients · Pregnant women in rural Nepal | 10 mg | 400 mcg | — | — |
| Acute autonomic effects of vitamins and fats in male smokers 2009 · moderate vitamins · Male smokers, mean age 34.2 years (SD 6.9) | 75 IU | 1 mg | 1 day | 30 |
| Acute autonomic effects of vitamins and fats in male smokers 2009 · high doses of vitamins · Male smokers, mean age 34.2 years (SD 6.9) | 800 IU | 5 mg | 1 day | 30 |
| A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia 2010 · NF group, 3-month blinded trial · Community-dwelling adults aged 18–86 years, both sexes, without dementia or clinical memory difficulties | 30 IU | 400 mcg | 90 days | 59 |
| A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia 2010 · Open-label NF group, separate 6-month trial · Community-dwelling adults, both sexes, without dementia or clinical memory difficulties | 30 IU | 400 mcg | 26 weeks | 38 |
| A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia 2010 · NF group, 2-week blinded trial · Community-dwelling adults, both sexes, without dementia or clinical memory difficulties | 30 IU | 400 mcg | 2 weeks | — |
| Cardiovascular effects of oral Supplementation of vitamin C, E and folic acid in young healthy males 2004 · vitamin intervention · 31 young healthy male adults; 14 received the vitamin intervention | 800 mg | 10 mg | 12 weeks | 14 |
| Ascorbate is depleted by smoking and repleted by moderate supplementation: a study in male smokers and nonsmokers with matched dietary antioxidant intakes 2000 · nonsmokers receiving vitamin cocktail · Male nonsmokers selected for low fruit and vegetable intake | 31 mg | 400 mcg | 90 days | 38 |
| Ascorbate is depleted by smoking and repleted by moderate supplementation: a study in male smokers and nonsmokers with matched dietary antioxidant intakes 2000 · smokers receiving vitamin cocktail · Male smokers selected for low fruit and vegetable intake | 31 mg | 400 mcg | 90 days | 37 |
| Antenatal Multiple Micronutrient Supplementation Compared to Iron-Folic Acid Affects Micronutrient Status but Does Not Eliminate Deficiencies in a Randomized Controlled Trial Among Pregnant Women of Rural Bangladesh 2019 · MM · Pregnant women aged 12–45 years in rural Bangladesh | 15 mg | 600 mcg | 165 days | 749 |
| Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease 2015 · Active group (RCT1, RCT2 and RCT3) · Men and women aged 50 years or older with mild or mild-to-moderate Alzheimer's disease; RCT3 participants were on stable approved Alzheimer's medication, while RCT1 and RCT2 participants were drug-free for Alzheimer's medication. | 40 mg | 400 mcg | 24 weeks | 501 |
| Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease 2015 · Active product during open-label extension (OLE) · Men and women aged 50 years or older with mild Alzheimer's disease who completed RCT2. | 40 mg | 400 mcg | 24 weeks | 201 |
| Newborn micronutrient status biomarkers in a cluster-randomized trial of antenatal multiple micronutrient compared with iron folic acid supplementation in rural Bangladesh 2020 · MM · Pregnant women in rural Bangladesh; age range not specified; no disease condition specified | 15 mg | 600 mcg | — | 176 |
| Multiple Micronutrient Powder Reduces Vitamin E Deficiency in Brazilian Children: A Pragmatic, Controlled Clinical Trial 2019 · intervention group · Children aged 6–9 months at the start of the study, male or female, attending primary health care centers in Goiânia, Brazil | 5 mg | 150 mcg | 90 days | 107 |
| Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial 2006 · Antioxidant vitamins plus B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset | 800 IU | 5 mg | 2 weeks | 24 |
| Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD 2009 · Treatment group · Adults with stage 2 to 4 chronic kidney disease and creatinine clearance of 15 to 70 mL/min/1.73 m² | 300 mg | 5 mg | 2 years | 47 |
| Effects of milk enriched with omega-3 fatty acid, oleic acid and folic acid in patients with metabolic syndrome 2006 · test group · Patients with metabolic syndrome; age and sex not specified | 7.5 mg | 150 mcg | 90 days | 36 |
| The impact of a standardized micronutrient supplementation on PCOS-typical parameters: a randomized controlled trial 2019 · Multinutrient supplementation group · Women aged 19–35 with polycystic ovary syndrome (PCOS) | 30 mg | 800 mcg | 90 days | 30 |
| Use of Nutraceuticals in Elderly to Fight Inflammation and Immuno-Senescence: A Randomized Case-Control Study 2022 · TG1 · Hospitalized adults older than 65 years; sex not restricted; recruited for causes other than cancer, with specified immune-disease and infection exclusions | 45 mg | 200 mcg | 12 weeks | 30 |
| Use of Nutraceuticals in Elderly to Fight Inflammation and Immuno-Senescence: A Randomized Case-Control Study 2022 · TG2 · Hospitalized adults older than 65 years; sex not restricted; recruited for causes other than cancer, with specified immune-disease and infection exclusions | 90 mg | 400 mcg | 6 weeks | 30 |
| Effects of baked products enriched with n-3 fatty acids, folates, β-glucans, and tocopherol in patients with mild mixed hyperlipidemia 2012 · active diet · Adults with mild plasma lipid abnormalities (mild mixed hyperlipidemia) | 120 mg | 1.6 mg | 30 days | 16 |